Loss of immunological tolerance to beta cell antigens is one of the driving mechanisms in type 1 diabetes (T1D) development in both humans and non-obese diabetic (NOD) mice, resulting in the activation and expansion of diabetogenic CD4+ and CD8+ T cells that mediate destruction of the pancreatic insulin-producing beta cells. The gene discussed is CD8A; the disease is type 1 diabetes mellitus.